They had to give it also in the U.S. to get approval, so I think there were three U.S. patients in upstate New York who were part of the trial.

Of a drug that Dr. Bell created in '81

You have to go to the clinic to do it.

So, the problem is that the clinical trial was done, and we were a part of it, and in the fundamental clinical trial the pivotal clinical trial we call the Phase Three, we refused to use a placebo.

And so if you think about it, the depressing thing is that

The first of these is informed consent.

And these devices are getting smaller and going into more and more of these patients.

We asked our control algorithm, are those 69 patients by the way, you'll notice that's four times the number of patients in the clinical trial can we look at those patients and say,

Novocure conducted its first phase three randomized trial in patients with recurrent GBM.

That's about it.

I presided over so many scenes like this.

I do not stand here today to suggest in any way that conducting HlV clinical trials in developing countries is bad.

From the point of view of the experiencing self, clearly, B had a worse time.

Now, researchers need to make every effort to ensure that an intervention that has been shown to be beneficial during a clinical trial is accessible to the participants of the trial once the trial has been completed.

The final point I would like for you to consider tonight is what happens to participants in the clinical trial once the research has been completed.

We can do high frequency monitoring to get objective data.

So we know it can work.

Now, this is subject to a lot of debate and controversy.

One of the most fundamental clinical trials in cancer came out in February in the New England Journal of Medicine, where they took women who were pre menopausal with breast cancer.

There was, it turns out, a second clinical trial.

Three years ago, she entered the Novocure lung cancer trial.

The cells genetically know what to do, and they start beating together.

(Laughter)

It's actually scary. It's beautiful.

that's why when the brain stem dies doctors can be certain, that the patient is clinically dead.

Maybe it even got published in a high profile scientific journal.

The amazing thing is another company did the right scientific trial, where they gave half placebo and half the drug.

Examination?

I think it is absolutely wrong for research to begin in the first place without a clear plan for what would happen to the participants once the trial has ended.

As we speak, there are 117 or so clinical trials researching the use of stem cells for liver diseases.

So, we went back, and we've been working harder yet.

There are 170 clinical trials investigating the role of stem cells in heart disease.

The material is actually being coated with the cells.

There are four major conferences on building blood cell sized devices there are many experiments in animals.

In this case here, a new, wearable bio reactor has been designed it should be tested clinically later this year at ISR by Joerg Gerlach in Pittsburgh.

This is an investigational technology, but, in clinical trials, we're seeing a 44 to 64 percent decrease in chronic pain patients.

At this point, he was told by his doctors that he had about 3 months to live.

It recently came out that experts trialing drugs before they come to market typically trial drugs first, primarily on male animals and then, primarily on men.

Well, here I can't help but think of the groundbreaking clinical trials recently conducted at East Carolina University that showed that online games can outperform pharmaceuticals for treating clinical anxiety and depression.

As part of a clinical trial for sleep disorders.

You all know about embryonic stem cells.

Or should they be given an alternative standard of care, such as the best current treatment available in the country in which the research is being conducted?

My diary

The things you see can be very complicated indeed.

Novocure's also working on lung cancer as the second target.